In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Webcasts 13th Annual Meeting

ESC Working Group on Myocardial & Pericardial Diseases

NOW Available online:

Webcasts resources from the 13th Annual Meeting
13-15 October 2016, Warnemünde - Germany



Educational courses during the 13th WG Annual meeting

Educational session 1: Diagnosis of cardiomyopathies

Chairs: A.L. Caforio, S.B. Felix


Introduction


Definition and classification -an overview - Y. Pinto


Genetic testing is superior to biopsy of the myocardium in cardiomyopathy - Prof. H. Katus

 


Contra - H.-P. Schultheiss


Advances in imaging: echocardiography, MRI, CT and PET – what is essential for diagnostic work-up? - A. Linhart


The MOGE(S) Classification for a phenotype- genotype nomenclature of cardiomyopathy - E. Arbustini

 


Prognostic Relevance of gene-environment interactions in patients with dilated cardiomyopathy - S. Heymans

 

Educational session 2: Personalized medicine for diagnosis and treatment of myocarditis and inflammatory cardiomyopathy

Chairs: A. Anastasakis, R. Jahns


Diagnostic work up in myocarditis and DCM - M. Dörr


Endomyocardial biopsy is essential for diagnosis - C. Basso


Role of cardiovascular magnetic resonance - J. Schulz-Menger

 


From evidence-based treatment to future direction for research in inflammatory cardiomyopathy - U. Eriksson

 

Educational session 3: Hypertrophic cardiomyopathy: From bench to bedside

Chairs: P. Elliott, A. Rigopoulos


Stepwise approach for risk stratification - P. Elliott


Next generation genetic testing – What next - J. Mogensen


Gene therapy for inherited sarcomeric pediatric cardiomyopathy - L. Carrier

 


Evidence-based medical treatment - J. Olivotto


Evidence-based percutaneous gradient ablation - H. Seggewiss


Surgical therapies - P. Ferrazzi

 

Educational session 4: Myocardial involvement in systemic immune-mediated diseases: Focus on the myocardial and pericardial disease Position paper

Chairs: E. Arbustini, A. L. Caforio


Systemic autoimmune diseases and cardiac involvement: Focus on animal models and common mechanisms -V. Poli


What’s new: The cardiac pathologist’s point of view -K. Klingel


What’s new: The cardiologist’s point of view -S.B. Felix

 



What’s new: The immunologist’s point of view -R. Marcolongo


What next -U. Eriksson




 

Extra-educational session 4: The Noncoding genome in myocardial diseases – Pathogenic implications and therapeutic perspectives for the cardiomyopathies

Chairs: M. Arad, P. Charron


Noncoding RNAs in cardiovascular disease – Status of clinical translation - T. Thum


MicroRNAs in cardiac fibrosis and hypertrophy - S. Engelhardt


Monocyte-directed RNAi in cardiac inflammation - F. Leuschner

 


Gene editing - J.-S. Hulot


Methylome - B. Meder


Gene and microRNA based therapies for heart failure Status of clinical translation - R. Hajjar

 

Extra educational session 5: Diastolic and systolic dysfunction in heart failure and the cardiomyopathies   – From diagnosis to treatment

Chairs: M. Fu, A. Ristic


Immunoadsorption as a treatment option in DCM - S. B. Felix


Current evidence on treatment of patients with chronic systolic heart failure - A. Ristic


Cardiac implantable electronic devices in systolic heart failure - M. Busch

 


Systolic heart failure: New drugs in the pipeline - B. Pieske


New treatment options for diastolic dysfunction - G. Hasenfuß


Keynote Lecture - Myocardial regeneration in the cardio- myopathies – A therapeutic option? Basic research - T. Eschenhagen

 


Clinical trials - S. Janssens

 

Educational session 5: Rare myocardial diseases – From diagnosis to treatment

Chairs: A. L. Caforio, M. Dörr


Pediatric diseases - G. Limongelli


Anderson-Fabry disease - A. Linhart


Glycogen storage disease - M. Arad

 


Amyloidosis - C. Rapezzi


Neuro-muscular disease - A. Pantazis


Inflammatory cardiomyopathies - C. Basso

 


Keynote Lecture: Rare cardiomyopathies-challenges and opportunities - P. Elliott

 

Educational session 6: Diagnosis and treatment of pericardial diseases – Focus on the 2015 Guidelines

Chairs: S. Pankuweit, A. Ristic


Clinical and diagnostic work-up - B. Maisch


Medical treatment - M. Imazio


What next - Y. Adler

 

Educational session 7: Acute decompensated chronic heart failure – A diagnostic and therapeutic challenge in cardiomyopathies of different aetiologies

Chairs: S. Blankenberg, A. Keren


The diagnostic accuracy of the natriuretic peptides in heart   failure - J. Mant


New drugs for treatment of acute decompensated heart failure – Mitrovic


Ultrafiltration in patients with acute decompensated chronic heart failure - G. Marenzi

 


Impella ventricular support in patients with cardiogenic shock - M. Ferrari


Emergency extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock – D. Westermann


Keynote Lecture: Auto-immune mechanisms in myocarditis and  dilated cardiomyopathy - A. L. Caforio

 

Educational session 8: Arrhythmogenic cardiomyopathies

Chairs: A. Anastasakis, P. Elliott


Pathology – Still the gold standard? C. Basso


Genetic diagnosis – An update for the clinician - E. Arbustini


Clinical and non-invasive work-up - A. Tsatsopoulou

 


Risk stratification - T. Wichter


Keynote Lecture: Treatment of ARVC: Key messages from the international and future perspectives - D. Corrado